The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
93.279 |
PAR-19-064 |
| The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs) |
93.941 |
RFA-PS-19-001 |
| Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum |
93.941 |
RFA-PS-19-003 |
| Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-18-010 |
| NINR Clinical Trial Planning Grant (R34 Clinical Trial Required) |
93.361 |
PAR-19-060 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
93.361 |
PAR-19-057 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
93.361 |
PAR-19-058 |
| NEA USArtists International, FY2019 |
45.024 |
NEAPS1806 |
| Fox River NRDA |
15.658 |
F19AS00032 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
93.113, 93.172, 93.242, 93.279, 93.286, 93.307, 93.853, 93.855, 93.866 |
PA-19-052 |
| Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.351, 93.361, 93.393, 93.394, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.879 |
PA-19-056 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
93.113, 93.172, 93.173, 93.273, 93.279, 93.307, 93.361, 93.846, 93.855, 93.866 |
PA-19-054 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.273, 93.279, 93.307, 93.361, 93.846, 93.855, 93.866, 93.867, 93.879 |
PA-19-053 |
| Research Project Grant (Parent R01 Clinical Trial Required) |
93.113, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867 |
PA-19-055 |
| Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.279, 93.313, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-19-010 |
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-004 |
| Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) |
93.242, 93.855 |
PA-19-042 |
| Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) |
93.242, 93.855 |
PA-19-050 |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required) |
93.353, 93.394 |
RFA-CA-19-018 |
| New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PA-19-049 |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839 |
PAR-19-048 |
| Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-18-014 |
| Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) |
93.286, 93.353, 93.393, 93.395, 93.866 |
RFA-CA-19-013 |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) |
93.173 |
PA-19-047 |
| Family Self-Sufficiency Program - Renewal |
14.896 |
FR-6200-N-04 |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) |
93.173 |
PA-19-046 |
| End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) |
93.361 |
PAR-19-044 |
| End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) |
93.361 |
PAR-19-045 |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.273, 93.353, 93.853, 93.855 |
RFA-CA-19-015 |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.353, 93.853 |
RFA-CA-19-014 |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3) |
93.113, 93.121, 93.353, 93.393, 93.853 |
RFA-CA-19-012 |
| Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional) |
93.866 |
RFA-AG-20-002 |
| Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional) |
93.866 |
RFA-AG-20-001 |
| Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-003 |
| Fair Housing Initiatives Program - Private Enforcement Initiative |
14.418 |
FR-6200-N-21-C |
| Fair Housing Initiative Program - Education and Outreach Initiative |
14.416 |
FR-6200-N-21A |
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.853, 93.866 |
RFA-AT-19-001 |
| Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional) |
93.121, 93.173, 93.213, 93.242, 93.273, 93.361, 93.853, 93.867 |
RFA-NS-19-008 |
| Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.268, 93.273, 93.361, 93.853, 93.867 |
RFA-NS-19-009 |
| Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) |
93.242 |
RFA-MH-19-235 |
Search Results 6001-6040 of 17930
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 [Next] |
